Cargando…
AB70. Controversies in male hypogonadism
Over the past 5 years the testosterone supplementation therapy (TST) market has grown rapidly. Testosterone is now the second fastest growing medication in the United States. From 2005 to 2009 spending on testosterone jumped 115.5%, and the number of prescriptions filled increased 64.5%. There are m...
Autor principal: | Khera, Mohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708427/ http://dx.doi.org/10.3978/j.issn.2223-4683.2014.s070 |
Ejemplares similares
-
AB63. Controversial issues in erectile dysfunction
por: Jiann, Bang-Ping
Publicado: (2014) -
AB029. The beneficial effects of pulsatile gonadotropin-releasing hormone pumps in the treatment of adult male idiopathic hypogonadotropic hypogonadism
por: Li, Yan-Feng, et al.
Publicado: (2018) -
AB021. What and how should we monitor to diagnose and treat hypogonadism?
por: Park, Jong Kwan
Publicado: (2016) -
AB018. Androgen receptor CAG repeat length polymorphism as a risk factor of late onset hypogonadism/metabolic syndrome in a Korean male population
por: Moon, Du Geon, et al.
Publicado: (2017) -
AB30. Effects of varicocele on male infertility
por: Tan, Yan
Publicado: (2014)